Stock Option Scheme Linked to EBITDA Targets
First written in FY2017. 2 of 3 entries say "Reframed", first in FY2022-Q3. Latest entry: FY2025.
RenetJapanGroup moved to the "Worse" side of this theme in 2022, 2 years before the typical company in this theme (2024).
3 other companies' latest entry also says "Reframed".
- FY2025ReframedAnnual report
「Stock acquisition rights holders may exercise these stock acquisition rights thereafter only if operating profit stated in the Company's consolidated income statement exceeds ¥1.5 billion in any fiscal year from the fiscal year ending September 2026 through the fiscal year ending September 2030.」
In addition to the previous EBITDA-linked stock acquisition rights, Series 23 stock acquisition rights establish a plan under which operating profit exceeding ¥1.5 billion in any fiscal year from the fiscal year ending September 2026 through the fiscal year ending September 2030 is an exercise condition. - FY2022-Q3ReframedAnnual report
「If EBITDA exceeds ¥1.2 billion in any fiscal year from the fiscal year ending September 2023 through the fiscal year ending September 2025, or exceeds ¥1.5 billion in any fiscal year from the fiscal year ending September 2023 through the fiscal year ending September 2027, these stock acquisition rights may be exercised thereafter.」
In addition to the existing EBITDA-linked stock acquisition rights plan, the Company established new eligible fiscal years and EBITDA conditions of ¥1.2 billion and ¥1.5 billion for Series 21 stock acquisition rights. - FY2017First statedAnnual report
「If EBITDA for any fiscal year from the fiscal year ending September 2018 through the fiscal year ending September 2019 exceeds ¥300 million, ¥500 million or ¥700 million, the beneficiary may exercise 50%, 75% or 100%, respectively, of these stock acquisition rights.」
For Series 14 through Series 16 stock acquisition rights, tiered exercise conditions have been established for multiple periods from the fiscal year ending September 2018 through the fiscal year ending September 2027, based on EBITDA thresholds of ¥300 million, ¥500 million and ¥700 million; ¥600 million, ¥900 million and ¥1.2 billion; and ¥1 billion, ¥1.5 billion and ¥2 billion, respectively.